Identifies carbapenem resistance in Providencia huaxiensis, indicating a public health threat.
In recent years, clinical Providencia species harboring carbapenemase-encoding genes have been increasingly reported, posing significant challenges in public health. However, Providencia huaxiensis ( P. huaxiensis ) isolates producing NDM have rarely been documented. Here, we report a carbapenem-resistant Providencia strain, PR66, which was initially misidentified as P. rettgeri . Antimicrobial susceptibility testing revealed resistance to all tested agents, including carbapenems. Species-level identification was confirmed using the average nucleotide identity (ANI) and digital DNA–DNA hybridization (dDDH). Whole-genome sequencing and bioinformatics analysis revealed that PR66 possesses a circular chromosome and three plasmids. The chromosome and plasmid pPR66.2 encode multiple resistance genes, including bla NDM-1 , bla OXA-4 , bla OXA-10 , bla MOX-3 , aph(3’)-Ia , aph(3”)-Ib , aph(3’)-VIb , aph(6)-Id , aac(6’)-Ib3 , ant(2”)-Ia , aadA , tet(B) , among others. Notably, the bla NDM-1 gene is located on a novel integrative and conjugative element (ICE), ICE Phu Chn-PR66, which also harbors additional resistance genes. This ICE spanned 127,074 bp (positions 3,989,454–4,116,527 bp) and had a GC content of 48.6%. It was site-specifically integrated into the prfC locus of the PR66 chromosome. Conjugation and genetic stability assays confirmed the successful transfer of bla NDM-1 to Escherichia coli C600, with stable inheritance in the recipient strain. These findings underscore the role of ICEs in disseminating carbapenem resistance within P. huaxiensis and potentially across other bacterial species.
No takes yet. Share an insight, caveat, or question.
Tao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: